CTOs on the Move

ConnectDoc

www.connectdoc.com

 
The team at ConnectDoc consists of technical advisors, operational and procedural experts, market development specialists, and physician led medical direction. We offer innovative home monitoring, hospital, and physician solutions to improve patient care and quality.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Chrono Therapeutics

We provide more. We are building a next generation transdermal drug delivery wearable that integrates biologically-timed drug delivery with personalized digital support to help people achieve optimal clinical outcomes and lifestyle improvements.

Reeves-Sain

Reeves-Sain is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Link

Health Link is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Solstice Medical

Solstice Medical is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Insulet

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.